Literature DB >> 12958229

Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method.

James E Cummins1, Julie M Villanueva, Tammy Evans-Strickfaden, Shekou M Sesay, Sheila R Abner, Timothy J Bush, Timothy A Green, Jeffrey L Lennox, Thomas Wright, Thomas M Folks, Clyde E Hart, Charlene S Dezzutti.   

Abstract

Infectious human immunodeficiency virus type 1 (HIV-1) is difficult to detect in female genital secretions by standard virus culture techniques. To improve detection of cell-free HIV-1 in female genital secretions, we adapted a short-term assay that uses the multinuclear-activation galactosidase indicator (MAGI) assay. When vaginal lavages from HIV-1-infected women were tested with the adapted MAGI assay, 25 (64%) of 39 lavages with detectable, cell-free HIV-1 RNA were shown to have infectious virus. No infectious virus was found in 10 vaginal lavages from HIV-1-infected women with undetectable vaginal viral loads. Significantly (P < 0.01) more lavages from HIV-1-infected women tested positive for infectious virus by the MAGI assay than by standard peripheral blood mononuclear cell (PBMC) coculture, which detected infectious virus in only 6 (17%) of 35 vaginal lavages. Lavages with viral loads of >10,000 copies per lavage yielded significantly (P < 0.01) more positive cultures than those with <10,000 copies by using the MAGI assay. Detection of infectious HIV-1 in vaginal lavages was not associated with the presence of genital tract infections or CD4(+)-T-cell counts. However, although the results were not significant (P = 0.08), the MAGI assay detected infectious virus from more vaginal lavages at a vaginal pH of >/=4.5 than at a pH of <4.5. These results indicate that the MAGI assay is more sensitive than PBMC culture methods for detecting infectious virus in female genital secretions. Accurate measurements of infectious virus in genital secretions will improve studies that evaluate sexual transmission of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958229      PMCID: PMC193780          DOI: 10.1128/JCM.41.9.4081-4088.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner.

Authors:  M A Pedraza; J del Romero; F Roldán; S García; M C Ayerbe; A R Noriega; J Alcamí
Journal:  J Acquir Immune Defic Syndr       Date:  1999-06-01       Impact factor: 3.731

2.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

3.  Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.

Authors:  A Saracino; M Di Stefano; J R Fiore; A Lepera; D Raimondi; G Angarano; G Pastore
Journal:  New Microbiol       Date:  2000-01       Impact factor: 2.479

4.  Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.

Authors:  S D Lawn; S Subbarao; T C Wright; T Evans-Strickfaden; T V Ellerbrock; J L Lennox; S T Butera; C E Hart
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

5.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

6.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

Authors:  H L Martin; B A Richardson; P M Nyange; L Lavreys; S L Hillier; B Chohan; K Mandaliya; J O Ndinya-Achola; J Bwayo; J Kreiss
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

7.  Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration.

Authors:  T C Wright; S Subbarao; T V Ellerbrock; J L Lennox; T Evans-Strickfaden; D G Smith; C E Hart
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

8.  Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.

Authors:  L A Panther; L Tucker; C Xu; R E Tuomala; J I Mullins; D J Anderson
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

9.  Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team.

Authors:  R H Gray; N Kiwanuka; T C Quinn; N K Sewankambo; D Serwadda; F W Mangen; T Lutalo; F Nalugoda; R Kelly; M Meehan; M Z Chen; C Li; M J Wawer
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

10.  Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1.

Authors:  A Alfsen; P Iniguez; E Bouguyon; M Bomsel
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

View more
  8 in total

Review 1.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

2.  Effect of topical microbicides on infectious human immunodeficiency virus type 1 binding to epithelial cells.

Authors:  Susan Roth; Michael Monsour; Amanda Dowland; Patricia C Guenthner; Kelly Hancock; Chin-Yi Ou; Charlene S Dezzutti
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

3.  Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.

Authors:  Lucy R Mukura; Mimi Ghosh; John V Fahey; Susan Cu-Uvin; Charles R Wira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

4.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

5.  Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.

Authors:  Mimi Ghosh; Zheng Shen; John V Fahey; Susan Cu-Uvin; Kenneth Mayer; Charles R Wira
Journal:  Immunology       Date:  2009-07-18       Impact factor: 7.397

6.  Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.

Authors:  Anthony S Ham; Marilyn R Cost; Alexandra B Sassi; Charlene S Dezzutti; Lisa Cencia Rohan
Journal:  Pharm Res       Date:  2008-11-11       Impact factor: 4.200

7.  Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model.

Authors:  Stuart S Olmsted; Kristen V Khanna; Erina M Ng; Steven T Whitten; Owen N Johnson; Richard B Markham; Richard A Cone; Thomas R Moench
Journal:  BMC Infect Dis       Date:  2005-09-30       Impact factor: 3.090

8.  Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles.

Authors:  Yeruva Samrajya Lakshmi; Prashant Kumar; Golla Kishore; C Bhaskar; Anand K Kondapi
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.